Both in Pharmaceuticals
Eton Pharmaceutcials vs UroGen Pharma
Over the past year ETON returned +190.5% and URGN returned +58.7%; their daily moves had a correlation of 0.08.
ETON +190.5% URGN +58.7%Growth of $1, one year, split-adjusted
| Metric | ETON | URGN |
|---|---|---|
| Price | $52.18 | $32.72 |
| Market cap | $1.49B | $1.60B |
| Today | −2.78% | −2.27% |
| 1 month | +0.4% | −19.3% |
| 6 months | +80.6% | +42.3% |
| Year to date | +208.6% | +39.7% |
| 1 year | +185.0% | +65.4% |
| Revenue growth (YoY) | +98.6% | +199.2% |
| Gross margin | 67.6% | 90.9% |
| Net margin | 30.8% | −19.8% |
| P/E (TTM) | 117.5× | — |
| Price / sales | 14.1× | 8.5× |
| Net cash | -$1.1M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 90.3% | 41.3% |
| Short % of float | 7.6% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).